moxifloxacin has been researched along with ipragliflozin in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (ipragliflozin) | Trials (ipragliflozin) | Recent Studies (post-2010) (ipragliflozin) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 175 | 45 | 172 |
| Protein | Taxonomy | moxifloxacin (IC50) | ipragliflozin (IC50) |
|---|---|---|---|
| Sodium/glucose cotransporter 1 | Homo sapiens (human) | 1.876 | |
| Sodium/glucose cotransporter 2 | Homo sapiens (human) | 0.0076 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abeyratne, A; Dietz, A; Kadokura, T; Keirns, J; Krauwinkel, W; Smulders, R; Zhang, W | 1 |
1 trial(s) available for moxifloxacin and ipragliflozin
| Article | Year |
|---|---|
Ipragliflozin does not prolong QTc interval in healthy male and female subjects: a phase I study.
Topics: Adult; Aza Compounds; Black or African American; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Fluoroquinolones; Glucosides; Healthy Volunteers; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Thiophenes; White People; Young Adult | 2013 |